HOB Biotech Group Corp Ltd (688656) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.019x

Based on the latest financial reports, HOB Biotech Group Corp Ltd (688656) has a cash flow conversion efficiency ratio of 0.019x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.28 Million ≈ $2.24 Million USD) by net assets (CN¥820.01 Million ≈ $119.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688656 market cap overview for the company's overall valuation and market capitalisation.

HOB Biotech Group Corp Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how HOB Biotech Group Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HOB Biotech Group Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HOB Biotech Group Corp Ltd ranked by their cash flow conversion efficiency. Explore HOB Biotech Group Corp Ltd (688656) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sichuan Zigong Conveying Machine Group Co Ltd SHE:001288	-0.063x
Babcock & Wilcox Enterprises Inc NYSE:BW	-0.304x
SINOPEC Engineering (Group) Co. Ltd F:1NS	-0.016x
Plejd AB (publ) F:3CA	0.115x
British American Tobacco PLC LSE:BATS	0.053x
Frey SA PA:FREY	0.059x
Upwork Inc NASDAQ:UPWK	0.101x
CHINA FOODS UNSP.ADR/20 F:CFH0	N/A

Annual Cash Flow Conversion Efficiency for HOB Biotech Group Corp Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of HOB Biotech Group Corp Ltd from 2016 to 2025. View current stock price of HOB Biotech Group Corp Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥820.01 Million ≈ $119.99 Million	CN¥72.94 Million ≈ $10.67 Million	0.089x	-28.63%
2024-12-31	CN¥812.14 Million ≈ $118.84 Million	CN¥101.22 Million ≈ $14.81 Million	0.125x	-1.61%
2023-12-31	CN¥810.73 Million ≈ $118.64 Million	CN¥102.69 Million ≈ $15.03 Million	0.127x	+69.36%
2022-12-31	CN¥779.57 Million ≈ $114.08 Million	CN¥58.31 Million ≈ $8.53 Million	0.075x	-45.04%
2021-12-31	CN¥770.00 Million ≈ $112.68 Million	CN¥104.79 Million ≈ $15.33 Million	0.136x	-51.76%
2020-12-31	CN¥206.39 Million ≈ $30.20 Million	CN¥58.22 Million ≈ $8.52 Million	0.282x	-38.44%
2019-12-31	CN¥149.64 Million ≈ $21.90 Million	CN¥68.57 Million ≈ $10.03 Million	0.458x	+31.16%
2018-12-31	CN¥133.12 Million ≈ $19.48 Million	CN¥46.51 Million ≈ $6.81 Million	0.349x	+24.05%
2017-12-31	CN¥79.03 Million ≈ $11.56 Million	CN¥22.26 Million ≈ $3.26 Million	0.282x	+148.76%
2016-12-31	CN¥56.71 Million ≈ $8.30 Million	CN¥6.42 Million ≈ $939.60K	0.113x	--

About HOB Biotech Group Corp Ltd

SHG:688656 China Medical Devices

Market Cap

$1.09 Billion

CN¥7.47 Billion CNY

Market Cap Rank

#8588 Global

#2068 in China

Share Price

CN¥117.53

Change (1 day)

-2.14%

52-Week Range

CN¥78.49 - CN¥213.11

All Time High

CN¥213.11